Viewing nowDapozin 5 mg (Dapagliflozin)
Dapagliflozin 5mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

MFDS item code 202102088 · Approved 2021.03.05 · Insurance code 647805140
Improvement of type 2 diabetes, prevention of worsening chronic heart failure, and prevention of worsening chronic kidney disease
This medication helps control blood sugar levels in patients with type 2 diabetes and can be used as an adjunct to dietary and exercise therapy. It also contributes to reducing the risk of death and hospitalization due to cardiovascular disease in patients with chronic heart failure. It aids in delaying the decline in kidney function in patients with chronic kidney disease and helps reduce the risk of cardiovascular disease and kidney-related mortality. This medication can be used alone or in combination with other therapies, and an appropriate therapeutic effect can be expected depending on the patient's condition. Overall, it is an effective drug for improving blood sugar control and cardiovascular and kidney health.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily, both as monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received antidiabetic drug therapy, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR below 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - eGFR below 25 mL/min/1.73m2: Initiation of this medicine is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. Swallow the tablet whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be administered to certain patients. For example, it should not be used in patients with allergies to the active ingredient or excipients, type 1 diabetes patients, those with diabetic ketoacidosis, patients with lactose intolerance or genetic metabolic disorders, and those undergoing dialysis. Additionally, caution should be exercised in patients with reduced fluid volume or poor kidney function. This medication can lower blood pressure and may pose a risk of acute kidney injury, so kidney function and fluid status should be closely monitored before and during treatment. It is best not to initiate this medication in patients with severely reduced kidney function. While taking this medication, side effects such as genital infections, urinary tract infections, hypoglycemia, dehydration, and diabetic ketoacidosis may occur, so symptoms should be closely observed. In particular, genital infections may occur more frequently in women, and hypoglycemia may occur more often when used with other diabetes medications such as insulin or sulfonylureas. Diabetic ketoacidosis may develop even when blood sugar levels are not high, so if symptoms such as vomiting, abdominal pain, or difficulty breathing occur, it is important to consult a healthcare professional promptly. This medication may affect kidney function, which can lead to elevated creatinine levels; these changes are usually temporary but require monitoring. Additionally, there is a rare risk of severe infections like necrotizing fasciitis, so if there is pain, swelling, or fever around the genital area, immediate medical attention should be sought. Use during pregnancy or breastfeeding is not recommended. Elderly patients are at increased risk of reduced kidney function and decreased fluid volume, thus requiring heightened caution. This medication may interact with other drugs, especially when used with diuretics, insulin, or sulfonylureas for diabetes, necessitating dosage adjustments. In the case of overdose, there is no specific antidote, so it is important to receive prompt treatment tailored to the symptoms. Finally, this medication does not significantly impact driving or machine operation, but caution should be exercised if there is a risk of hypoglycemia.
Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, polydipsia, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, urethritis, vulvar pruritus, genital pruritus, increased hematocrit, decreased renal creatinine clearance at the start of treatment, dyslipidemia, elevated blood creatinine at the start of treatment, elevated blood urea, weight loss, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, rash, angioedema, weakness, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, choledocholithiasis, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylaxis, paresthesia, cerebral infarction, nerve compression, sensory loss, headache, nasopharyngitis, upper respiratory infection, edema, fever, foreign body sensation, facial edema, facial pain, warmth, influenza-like syndrome, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularities, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcer, excessive sweating eczema, nummular eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, sweating, flank pain, fibromyalgia, limb discomfort, muscle cramps, musculoskeletal discomfort, osteoporosis, contusions, road traffic accident, drug overdose, ankle fracture, orbital fracture, foot fracture, gastrointestinal foreign body, hand fracture, pelvic fracture, laceration, ligament rupture, limb injury, meniscus injury, skin abrasion, tendon rupture, thoracic vertebra fracture, tibia fracture, dental injury, dry eye, ocular pain, retinal disorder, vision loss, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid edema, keratitis, ocular hypertension, visual impairment, vitreous floaters, oropharyngeal pain, allergic rhinitis, asthma, voice disorders, epistaxis, sputum, sleep apnea syndrome, wheezing, atherosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, atrial fibrillation, diastolic dysfunction, palpitations, anxiety disorder, nocturia, hallucinations, sleep disorder, insomnia, fatty liver, gallbladder polyp, tinnitus, anal genital warts, adenoma, neuroma, unspecified pituitary neoplasm, male hypogonadism, thyroid cyst, thyroid mass, food allergy, erythrocytosis, dyspepsia, nausea, diarrhea, vomiting, urinary retention, abnormal urination, increased alanine aminotransferase, increased aspartate aminotransferase, weight gain, decreased appetite, next symptom, increased appetite, taste disturbance, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, loss of consciousness, neuralgia, peripheral neuropathy, sleep disorder, syncope, tremor
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent contact with air or moisture and kept at room temperature between 1 and 30 degrees Celsius. Proper storage ensures the medication maintains its effectiveness and can be used safely.
Yellow, double convex, round film-coated tablets
30 tablets/box [10 tablets/PTP×3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin 5mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Dapagliflozin 10mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Dapagliflozin 5mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Dapagliflozin 10mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Dapagliflozin 10mg
Tablet · Prescription medication
Korea Prime Pharma Co., Ltd.
Dapagliflozin 10mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.
Dapagliflozin 10mg
Tablet · Prescription medication
IYUN Pharmaceutical Co., Ltd.
Dapagliflozin 10mg
Tablet · Prescription medication
Litepharmtech Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.